Related references
Note: Only part of the references are listed.Combination of 7-O-geranylquercetin and microRNA-451 enhances antitumor effect of Adriamycin by reserving P-gp-mediated drug resistance in breast cancer
Yuling Chen et al.
Aging-US (2022)
Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity
Ling He et al.
CARDIOVASCULAR TOXICOLOGY (2021)
Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
Pushkar Singh Rawat et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Regulation of microRNA-33, SREBP and ABCA1 genes in a mouse model of high cholesterol
Xianglun Zhang et al.
ARCHIVES ANIMAL BREEDING (2021)
A hMTR4-PDIA3P1-miR-125/124-TRAF6 Regulatory Axis and Its Function in NF kappa B Signaling and Chemoresistance
Chen Xie et al.
HEPATOLOGY (2020)
Dye binding assay reveals doxorubicin preference for DNA versus cardiolipin
Colin A. Fox et al.
ANALYTICAL BIOCHEMISTRY (2020)
MicroRNA-221 promotes breast cancer resistance to adriamycin via modulation of PTEN/Akt/mTOR signaling
Yingchun Yin et al.
CANCER MEDICINE (2020)
Exosomal LncRNA-NEAT1 derived from MIF-treated mesenchymal stem cells protected against doxorubicin-induced cardiac senescence through sponging miR-221-3p
Lei Zhuang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
Caspase-3-mediated GSDME activation contributes to cisplatin- and doxorubicin-induced secondary necrosis in mouse macrophages
Feng-Yi Mai et al.
CELL PROLIFERATION (2019)
Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring
Nadine Wenningmann et al.
MOLECULAR PHARMACOLOGY (2019)
Atherosclerosis
Peter Libby et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
miR-34b/c regulates doxorubicin-induced myocardial cell injury through ITCH
Wen-Cai Zhang et al.
CELL CYCLE (2019)
microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2
Huijuan Zeng et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2018)
Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress
Lisha Zhao et al.
REDOX BIOLOGY (2018)
Polyphenols, autophagy and doxorubicin-induced cardiotoxicity
S. Shabalala et al.
LIFE SCIENCES (2017)
Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
Navid Koleini et al.
ONCOTARGET (2017)
Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity
Abdelrahman Ibrahim Abushouk et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy
Na Guo et al.
RENAL FAILURE (2016)
Doxorubicin-Mediated Cardiotoxicity: Role of Mitochondrial Connexin 43
Michela Pecoraro et al.
CARDIOVASCULAR TOXICOLOGY (2015)
Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis
Denuja Karunakaran et al.
CIRCULATION RESEARCH (2015)
MicroRNA-101 overexpression by IL-6 and TNF-α inhibits cholesterol efflux by suppressing ATP-binding cassette transporter A1 expression
Nan Zhang et al.
EXPERIMENTAL CELL RESEARCH (2015)
Overview of MicroRNA Biology
Ashley M. Mohr et al.
SEMINARS IN LIVER DISEASE (2015)
MicroRNA-532-3p regulates mitochondrial fission through targeting apoptosis repressor with caspase recruitment domain in doxorubicin cardiotoxicity
J-X Wang et al.
CELL DEATH & DISEASE (2015)
Topoisomerase II and leukemia
MaryJean Pendleton et al.
BONE MARROW NICHE, STEM CELLS, AND LEUKEMIA: IMPACT OF DRUGS, CHEMICALS, AND THE ENVIRONMENT (2014)
Effects of miR-33a-5P on ABCA1/G1-Mediated Cholesterol Efflux under Inflammatory Stress in THP-1 Macrophages
Min Mao et al.
PLOS ONE (2014)
OxLDL up-regulates Niemann-Pick type C1 expression through ERK1/2/COX-2/PPARα-signaling pathway in macrophages
Xiaohua Yu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2012)
Role of HMGB1 in doxorubicin-induced myocardial apoptosis and its regulation pathway
Yongwei Yao et al.
BASIC RESEARCH IN CARDIOLOGY (2012)
A role of miR-33 for cell cycle progression and cell proliferation
Yasuko Iwakiri
CELL CYCLE (2012)
Mir-33 regulates cell proliferation and cell cycle progression
Daniel Cirera-Salinas et al.
CELL CYCLE (2012)
miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity
Ryan M. Allen et al.
EMBO MOLECULAR MEDICINE (2012)
Inhibition of AMP-activated Protein Kinase α (AMPKα) by Doxorubicin Accentuates Genotoxic Stress and Cell Death in Mouse Embryonic Fibroblasts and Cardiomyocytes ROLE OF p53 AND SIRT1
Shaobin Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang et al.
NATURE MEDICINE (2012)
Alteration of Topoisomerase II-Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based Chemotherapy
Michael F. Press et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune Responses
Laurent Yvan-Charvet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
miR-33 links SREBP-2 induction to repression of sterol transporters
Tyler J. Marquart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis
S. Hani Najafi-Shoushtari et al.
SCIENCE (2010)
MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
Katey J. Rayner et al.
SCIENCE (2010)
Topoisomerase IIβ-Mediated DNA double-strand breaks:: Implications in doxorubicin cardiotoxicity and prevention by dexrazoxane
Yi Lisa Lyu et al.
CANCER RESEARCH (2007)
ABVD versus modified Stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: Final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi
PG Gobbi et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt
R Fukazawa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2003)
Share Paper
